Concepedia

Shenglan Cai

SC

Statistics

Publications

5

Citations

157

H-Index

5

Active since

2019

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

Hunan University

Huaihua University

Shenglan Cai is an author at Central South University specializing in medicine, liver physiology, and immunology.

Top concepts

MedicineImmunologyLiver PhysiologyHepatologyCell BiologyPharmacologyTumor BiologyCancer ResearchMolecular PharmacologyTumor Microenvironment

Publications per year

2019–2023

5

Publications

5

Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma

Shanshan Lu, Shenglan Cai, Xiaozhen Peng et al. · Frontiers in Immunology · 2021 · 64 citations · Full text

Integrative Transcriptomic, Immunology, Immunoediting +17

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC

Xiaozhen Peng, Ruochan Chen, Shenglan Cai et al. · Frontiers in Oncology · 2021 · 30 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

Protective effects of specific cannabinoid receptor 2 agonist GW405833 on concanavalin A-induced acute liver injury in mice

Zebing Huang, Yixiang Zheng, Ning Li et al. · Acta Pharmacologica Sinica · 2019 · 22 citations · Full text

Inflammation, Molecular Pharmacology, Cannabis Use +12

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma

Shenglan Cai, Xingwang Hu, Ruochan Chen et al. · Frontiers in Genetics · 2021 · 22 citations · Full text

CB2R agonist GW405833 alleviates acute liver failure in mice via inhibiting HIF-1α-mediated reprogramming of glycometabolism and macrophage proliferation

Shenglan Cai, Xuegong Fan, Jie Wu et al. · Acta Pharmacologica Sinica · 2023 · 19 citations · Full text

Molecular Pharmacology, Hepatology, Medicine +10

1–5 of 5